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Viewpoint

The injustice of unfit clinical practice guidelines in
low-resource realities
Nanna Maaløe, Anna Marie Rønne Ørtved, Jane Brandt Sørensen, Brenda Sequeira Dmello, Thomas van den Akker, Monica Lauridsen Kujabi,
Hussein Kidanto, Tarek Meguid, Ib Christian Bygbjerg, Jos van Roosmalen, Dan Wolf Meyrowitsch, Natasha Housseine

To end the international crisis of preventable deaths in low-income and middle-income countries, evidence-informed
and cost-efficient health care is urgently needed, and contextualised clinical practice guidelines are pivotal. However,
as exposed by indirect consequences of poorly adapted COVID-19 guidelines, fundamental gaps continue to be
reported between international recommendations and realistic best practice. To address this long-standing injustice
of leaving health providers without useful guidance, we draw on examples from maternal health and the COVID-19
pandemic. We propose a framework for how global guideline developers can more effectively stratify recommendations
for low-resource settings and account for predictable contextual barriers of implementation (eg, human resources) as
well as gains and losses (eg, cost-efficiency). Such development of more realistic clinical practice guidelines at the
global level will pave the way for simpler and achievable adaptation at local levels. We also urge the development and
adaptation of high-quality clinical practice guidelines at national and subnational levels in low-income and middleincome countries through co-creation with end-users, and we encourage global sharing of these experiences.

Introduction
“The women are in pain, some look frightened and many
are calling for my attention. It is a typical night duty in the
maternity ward. Eighteen women are admitted in the
congested labour room, two in each bed. A young nurse
and I are the only staff in the room. I see a head crowning
in bed four and an oxytocin drip next to bed two running
too fast. The nurse reports that one of the women with
severe preeclampsia is fitting. It is a long time since any
woman had assessments of foetal heart rates, and their
unborn babies may have been crying out for help in
silence. I am quickly casting a glance on the room’s
wallpaper of guidelines. They all are there, from the
Ministry of Health to international aid organizations.
Fading instructions and illustrations depict the what-if
scenarios if only I had one woman with one illness at a
time. I force my gaze back at reality and feel alone”
(reconstruction of lived experiences of health professionals
in Tanzanian maternity units, unpublished data).
Each year, more than 295 000 maternal deaths and
5 million stillbirths and neonatal deaths occur worldwide,
of which the vast majority of these deaths take place in
low-income and middle-income countries (LMICs).1,2
Many of these deaths would be preventable with access to
quality health care during pregnancy and childbirth, and
the economic and psychosocial return on investment
would be massive for families and societies.3 However,
although the number of facility births have increased, the
quality of care has not adequately followed suit.
During the past two decades, the development of
clinical practice guidelines (CPGs) has been a central
strategy to cost-efficiently improve maternal health
care in low-resource settings.4–6 Moreover, the rapidly
expanding number of CPGs have laid the foundations for
a variety of other interventions. However, as we found in
a literature search of childbirth CPGs in African hospitals
(appendix p 4), fundamental gaps between international
recommendations and realistic best practice continue

to be reported in low-resource settings, and evaluation
of the implementation and effectiveness of CPGs is
largely neglected. Similar discrepancies between CPGs
and realistic best practice are reported in other fields
of medicine,7–9 and such discrepancies have also been
exposed by the interim COVID-19 guidelines (appendix
p 2).10,11 Within and beyond maternal health, these
discrepancies cause alarming risks of preventing actual
use of CPGs, disenfranchising and demoralising health
providers, draining resources, and, paradoxically, causing
unintentional harm in clinical practice.12–14 This issue
raises the question of whose views count in CPG
development, implementation, and aspiration?15
In this Viewpoint, we address this underexposed yet
long-standing injustice of leaving health providers
without useful guidance. We suggest ways forward, and
we call for action, at global and local levels, to develop
contextualised, realistic CPGs for health providers
practising where guidance is most acutely needed.

Whose perspectives count in current CPGs?
When comparing multiple international, high-quality
maternal health CPGs, important inconsistencies and
disagreements are seen, even between concurrently
published so-called high-quality CPGs.16 These incon
sistencies and disagreements highlight limitations in
experimental studies and the strong influence of values,
culture, and professional tradition, even in what are
considered high-quality CPGs.17 Translating evidence
into recommendations inevitably requires judgements
about the balance between benefits and risks, and
involves combining selective and restricted study
findings. However, the front-line health providers, who
are the experts in low-resource clinical practice and the
pivotal agents of sustainable development, are rarely
invited to participate in such judgements and tailoring.
Not only are these clinical experts scarcely represented
in CPG development, pilot testing among end-users of
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CPGs and postimplementation evaluation are largely
neglected.5
Multilateral health agencies appear to take for
granted that their CPGs will be adequately adapted to
local contexts regionally, nationally, or subnationally.4
However, it is generally acknowledged that few LMICs
are equipped with the necessary human, technical,
and financial resources to carry out such adaptations,
including time, access to evidence, knowledge and
training on synthesising and applying evidence, and
coordination of the different stakeholders.9,12,18,19
Therefore, international recommendations are typically
endorsed nationally after varying degrees of suboptimal
adaptation by a panel of experts, or even (inappropriately)
directly adopted. Front-line health providers are often not
invited to influence these processes of GPG development
or adaptation nationally, but they are asked to use CPGs
that are dangerously incomplete, irrelevant, impractical,
or outdated.12,18,19 Some of the CPGs are predictably
unachievable, which can catalyse stress and resistance to
change among already strained health providers, instead
of achieving goals and increasing commitment and job
satisfaction.14 For instance, spending 10 min half-hourly
with each labouring woman counting fetal heart rate
and contractions is mathematically impossible when
simultaneously caring for three or more women.19 Other
recommendations might appear achievable but are
resource consuming and harmful. For instance, risk
ratios of vaginal breech births versus caesarean sections
differ between high-resource and low-resource settings,
given that the surgical safety that can be achieved in
high-income countries (HICs) can rarely be met when
resources are scarce.20 Likewise, although the use of
oxytocin augmentation is recommended in LMICs as it
is in HICs, higher risks of adverse perinatal outcomes
are predictable in settings without one-to-one care and
poor surveillance, no electronic drip counts, and delayed
access to emergency surgery and blood transfusion.19 Yet
other recommendations might unintentionally over
influence practice, leaving other essential care further
under-resourced. As elaborated in the appendix (p 2),
WHO’s non-integrated, vertical COVID-19 guidelines is
an example of this. For instance, as COVID-19 symptoms
mimic obstetric emergencies, triaging women with
concomitant obstetric complications might be delayed if
vertical COVID-19 responses overinfluence care.10
Astonishingly, augmentation of the technical bar for
evidence synthesis in CPG development, which has
occurred over the past two decades, has not been matched
by a strengthened focus on pilot testing and post
implementation evaluation. This finding stands in
contrast to CPG research in HICs, and implementation
science in general, in which co-creation, pilot testing,
and postimplementation evalua
tion are acknowledged
to be central means for success.13,21,22 Notably, while
medications have to pass through multiple phases of
trials before approval, as well as post-approval

monitoring, CPGs (eg, for drug dosages and indications)
are often disseminated without any pilot testing or
postimplementation testing of effects, and side-effects. In
the original AGREE appraisal tool, the go-to tool to assess
methodological rigour in CPG development, pilot testing
was included as an integrated part of stakeholder
involvement. In the second version, however, pilot testing
was reduced to one of many additional suggestions
for what might be included in the methodological
assessment.6 Strengthening evidence synthesis of CPGs
could even, paradoxically, have counteracted the influence
of end-users, by predominantly focusing on evidence
generated through experimental study designs, which
control for the essential contextual factors.5,23

Making end-users’ perspectives count
At national and sub-national levels

From the scarce literature regarding co-created CPGs in
low-resource settings (appendix p 4),7,8,16 we present two
examples from sub-Saharan Africa in this Viewpoint.
Both examples provide elaborate descriptions of CPG
development and evaluation, and they expose potentially
essential factors for effectiveness in such processes.9,19
One example is a Kenyan approach to co-creation of
paediatric CPGs, which was carried out at national level
and applied top-down.9 The other example is the Zanzibar
initiative for obstetric CPGs (the PartoMa project), which
was based on a bottom-up approach, in which CPGs
were co-created with health providers in one hospital and
later scaled up.19 There are many similarities between
these programmes, which both followed overarching
principles of “problem-driven iterative adaptation”.13
First, locally identified problems led the structured
CPG development process, and CPGs were updated in
response to emerging local issues and other feedback
from end-users, as well as emerging external evidence.
Second, to ensure legitimate, relevant and supportable
recommendations, and to avoid CPG duplication and
contradictions, the co-creators included clinicians with
and without speciality training (ie, the end-users, while
taking their limited time into account) as well as other
stakeholders (eg, community members and policy
makers). Third, the end product was a short booklet of
integrated, basic routine and emergency management,
presented as infographics for busy health providers
without specialty training. Finally, the CPGs were
widely disseminated at knowledge and skills courses,
which included trainers who were directly involved in the
CPG co-creation (once in Kenya and recurring in
Zanzibar). The Kenyan CPGs have been integrated into
undergraduate and postgraduate paediatric training, and
CPGs from the PartoMa project are currently being
modified and tested in Dar es Salaam, Tanzania. Both
programmes have reported concurrent improvements in
clinical practice. Also, they report enthusiasm among
CPG co-creators and users, including greater appreciation
of the value and limitations of evidence and an emerging
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sense of ownership. An added benefit of CPG cocreations with end-users is that the need for better
evidence to inform CPG development processes in lowresource settings is disclosed.9,19,23
The Kenyan approach was used to develop CPGs
de novo, whereas the primary focus of the PartoMa
project was on adapting internationally-derived CPGs.9,19
Although de-novo synthesis might strengthen a sense
that the local team’s role “is not just to endorse global
recommendations”,9 high-quality contextualisation and
adaptation of international CPGs might have greater
potential to make the best use of scarce resources.7
However, CPG adaptation processes in low-resource
settings remain unrealistically time-consuming and
resource-draining because of the discrepancies between
externally derived CPGs and realistic best practice, and
due to missing information in the externally derived
CPGs (eg, on what human resources are needed to follow
recommendations, on cost-effectiveness, and on how the
values and preferences of the targeted population were
evaluated). High-quality CPGs that have already been
developed in comparable low-resource settings would
ease adaptation to new locations, and such development
experiences and products should be routinely shared
internationally.7,12,18,19,24 Moreover, as self-reflected by
WHO’s Guidelines Review Committee, tools for CPG
adaptation, implementation, and updating should be
planned from the beginning of each CPG development
and not merely “treated as afterthoughts”.5

At the global level
It should be achievable to develop useful and effective
CPGs at global level that are closer to realities in LMICs,
thereby paving the way for simpler adaptation. Although
there are some promising examples of more specific
CPGs with lesser need for adaptation (eg, for neonatal
resuscitation),25 the effectiveness of directly adopted
broader, integrated CPGs for complex clinical manage
ment is questionable (eg, intrapartum guidance to avoid
the underlying neonatal asphyxia; appendix p 4). To
take better account of linkages between interventions
and contexts in CPG development, WHO launched an
initiative in 2016 to broaden their evidence synthesis
and better incorporate qualitative data and complex
intervention research. This initiative resulted in the
WHO-INTEGRATE framework, which encourages a
structured process of reflections during CPG develop
ment (ie, integrating health benefits and harms, human
rights and sociocultural acceptability, financial and
economic considerations, health equity, equality, and nondiscrimination, societal implications and feasibility, and
health systems considerations).23 This framework can
hopefully assist in stratifying CPGs to different contexts
already at global level, so that the CPGs are in accordance
with, for example, health provider-to-patient ratios.
Notably, this approach would follow WHO’s long-standing
aspiration to develop “conditional recommendations”4

when interventions are suitable for some locations only, of
which the WHO’s essential drugs list is a successful
example.24
However, actual use of the WHO-INTEGRATE
approach might be challenged by the often scarce
number of complex implementation studies with
detailed descriptions of context.21 Hence, interpreting
and combining the findings of trials with restricted
real-world applicability is still a central part of CPG
development. Inspired by a model for large-scale CPG
development in HICs, we propose that context strati
fication based on pre-decided criteria, as depicted by the
WHO-INTEGRATE framework (eg, provider-to-patients
ratios), is viewed only as the first of three steps at
global level, after which iterative cycles of adaptation,
implementation, and evaluation are implemented
nationally and sub-nationally (appendix p 3).22 The
second step at global level should require field visits in
different settings, to identify less predictable barriers to
implementation and effectiveness, and to identify
possible side-effects. WHO’s Better Outcomes in Labour
Difficulty (BOLD) project provides an encouraging
example of such negotiation of best possible standards
among end-users and target populations in selected
Ugandan and Nigerian health facilities.26 Field visits
should also include assessment of risks for contradictive
recom
mendations, counterproductive guide
lines over
load, or vertical guidance over-influencing care. Finally,
merely distributing CPGs is not sufficient to reach highquality clinical decision making. Even easily adaptable
recommendations enter a local process of becoming
politically and institutionally embedded, and the third
step at global level concerns supporting this process.
This third step might, for instance, include development
of realistic performance measures for evaluation of
CPG use and effects, CPG-related undergraduate and
postgraduate training components, and user-friendly
CPG algorithms and manuals. Notably, the brief info
graphics in the aforementioned Kenyan and PartoMa
CPGs follow the evidence of decision science on the
centrality of heuristics in decision making. Also within
clinical practice in HICs, such fast and frugal clinical
decision support tools are called for, which should not
overwhelm health providers by their sheer volume of
recommendations, but should stimulate dialogue with
colleagues and patients (eg, by presenting pros and cons
lists) and assist with multiple simultaneous actions in
complex realities.27 Notably, particularly in resourcescarce settings with suboptimal undergraduate and
postgraduate training, CPGs could be a central means to
stimulate creativity and flexibility of the mind, which is
crucial to provide best possible care for the many with
the limited resources available.
Digital health, including artificial intelligence, might
become central in designing cost-efficient models for
CPGs targeting LMICs by, for instance: (1) assisting in
CPG development, such as systematic reviews, expert
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consensus, Delphi approaches, and data mining;
(2) developing CPGs with embedded algorithms, which
cost-efficiently stratify recommendations to resource
levels and other contextual features, and allow for the
possibility of rapid modifications; (3) strengthening CPG
use through digital decision support tools that reduce
workloads; and (4) embedding feedback loops to facilitate
rapid learning from end-users.28 However, in current
CPG-based digital decision-support tools for LMICs,
pre-made so-called best-practice eHealth solutions
often appear non-adjustably based on generic CPGs.
For instance, an evaluation in Kenya of an electronic
partograph to assist in timely surveillance during birth
raised concerns of how this potentially effective
intervention could be implemented at busy sites where
only a small number of health providers are available.
The electronic partograph releases audible reminders
when clinical measurements are due, but the intervention
developers and evaluators have not assessed contextual
feasibility of WHO’s recommendations for labour
surveillance, which were adopted directly into the
intervention.29

implementation, and with embedded feedback loops
to stimulate rapid experiential learning throughout
development and implementation. Funding constraints
can be argued as a central challenge that influences both
priority setting and quality of CPG development.5
Meanwhile, the current isomorphic mimicry of nations
adopting poorly fitting CPGs causes capability traps,
where scarce resources are effectively lost in developing
and implementing ineffective CPGs.13 The case is clear:
the need for evidence-informed and cost-efficient health
care without wastage is urgent in LMICs, within and
beyond maternal health, and translating evidence into
practice is most successful when contextual differences
and needs are factored into the decision-making
process.16,23,30 We believe that development and adaptation
of high-quality, contextualised, realistic CPGs will assist
health providers in saving lives rather than causing
immobility by a desire for perfection.
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Pragmatic CPG development might be criticised for
promoting suboptimal practices, inefficiently replicating
previous interventions, failing to meet global standards,
or prolonging the unacceptable status quo.13 We do
acknowledge ethical dilemmas in producing acceptable
guidance for unacceptable realities with the human
resources crisis at its centre. Yet, acceptable guidance is
a moral duty to deal with realities that must not be
accepted in the long run, but that do currently exist.
Settings with scarce resources should thoroughly
consider efficiency and equity of resource use, and
global health care should not imply identical health
care: “this is the balance between globalizing evidence
and localizing decisions that will improve health care
worldwide”.30 In line with the Paris Declaration on Aid
Effectiveness and the Accra Agenda for Action, this
redirection of accountability at global, national, and
subnational levels enables health providers in resourceconstrained facilities to improve control and influence
how problems and solutions are outlined at the global
level.15 Overworked birth attendants require access
to professional development and supervision, for which
realistic CPGs are fundamental.31 Such aspirations for
respectful work conditions (Sustainable Development
Goals 3c and 8·8) are pivotal for providing best possible
safe and respectful care and strengthening the account
ability of health systems (Sustainable Development
Goals 3.1, 3.2, and 5.1).

A call for action at global and local levels
In the era of personalised medicine in HICs,
context-stratified, realistic CPGs for LMICs are long
overdue. Such CPGs should be formulated to facilitate
e87
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